Related Experiment Videos
[Aromatase and breast cancer]
1University of Edinburgh, Edinburgh, Great Britain.
Voprosy Onkologii
|June 1, 2001
Summary
Aromatase enzyme activity in breast tissue produces estrogens, fueling hormone-dependent breast cancers. New drugs effectively block this enzyme, reducing estrogen and inhibiting tumor growth.
Area of Science:
- Biochemistry
- Endocrinology
- Oncology
Context:
- Aromatase enzyme activity is prevalent in breast cancers and adipose tissue.
- Local estrogen biosynthesis within the breast can promote hormone-dependent tumor growth.
- Factors regulating breast aromatase activity, such as growth factors, are not fully understood.
Purpose:
- To investigate the role of aromatase activity in breast cancer.
- To explore the potential of aromatase inhibitors in treating hormone-dependent breast cancer.
Summary:
- Aromatase activity, detected in vitro and in vivo, contributes significantly to endogenous estrogens in breast tissue.
- This local estrogen production may sustain the growth of hormone-dependent breast tumors.
- Estrogen biosynthesis in the breast is sensitive to aromatase inhibitors, including newer generations of drugs.
- These inhibitors profoundly block aromatase activity, reduce estrogen levels, and demonstrate anti-tumor effects in hormone-dependent breast cancer.
Impact:
- Highlights the significance of local estrogen biosynthesis in breast cancer.
- Demonstrates the therapeutic potential of aromatase inhibitors for hormone-dependent breast cancer.
- Suggests the existence of autocrine and paracrine regulatory loops for aromatase activity within breast tissue.